Rhodiola Extract (3% Salidroside) Powder

Rhodiola rosea root contains a class of bioactive compounds called salidrosides (also known as tyrosol glycosides), alongside rosavins, which are thought to influence monoamine neurotransmitter levels and the hypothalamic-pituitary-adrenal axis — the body's central stress-response system. Standardizing the extract to 3% salidroside content ensures a consistent, measurable concentration of one of its primary active constituents with each serving. This powdered extract is commonly used by adults looking to manage fatigue, support cognitive performance under demanding conditions, or complement an active lifestyle; it may also appeal to those who prefer adaptogenic herbs over stimulants. Typical research doses range from roughly 200 to 600 mg of a standardized extract daily, often taken in the morning or before a mentally or physically demanding task, and the bulk powder format allows flexible, precise dosing.